Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Anifrolumab helped a woman with severe lupus achieve remission when other treatments failed.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

MC-1R is present in skin cells and may help reduce inflammation.

Cepharanthine may help treat Equid herpesvirus type 8 by reducing oxidative stress.

The ACE1 gene variant doesn't affect long-COVID symptoms.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

ODC expression in mouse skin and tumors is varied and can be inhibited by retinoic acid or cycloheximide.

Integrating biological networks improves drug repurposing and ADR prediction.

Activated ras can protect kidney cells from a certain substance that causes cell death.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

17β-estradiol can reduce inflammation in the skin.

A young woman with severe symptoms of CPAN improved with intensive treatment but needed a leg amputation.

The combination of encorafenib and binimetinib caused few skin issues.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

Ruxolitinib can cause a delayed skin reaction on the nose.

Targeting ACE2 and TMPRSS2 may help prevent or treat COVID-19 in cancer patients.

Tofacitinib can cause a rare rash called SDRIFE, which resolves after stopping the drug.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Hydrophilic carbon dots cause one protein to clump more and prevent another from clumping.

Immunoadsorption successfully treated a man's resistant polymyositis.

DNCB helps regrow hair in alopecia areata patients, but safer alternatives are needed.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Rituximab improved her dermatomyositis better than usual treatments.

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Cepharanthine may help treat lung fibrosis by affecting certain immune cells.

RCDP NCs are promising anti-aging cosmetic ingredients that improve skin health by reducing oxidative stress and enhancing cell function.